Bone cement with a modified polyphosphate network structure stimulates hard tissue regeneration.

Current biodegradable cements face limitations in structural stability and tissue integration. Prior research has shown that materials like brushite cement dissolve at rates that may not align with tissue regeneration timelines. While calcification promotion is known in some cell types, it remains unclear how cement dissolution rates influence this process. No prior work had resolved how polyphosphate structures affect both mechanical and biological properties. This gap motivated the investigation of calcium polyphosphate cement (CpPC) as a potential alternative. The need for a material that balances degradation with cellular response remains unmet. CpPC’s unique amorphous structure offers a novel approach to this challenge. Understanding its dissolution and calcification effects could advance bone regeneration strategies.

This study aimed to evaluate a modified calcium polyphosphate cement (CpPC) for its potential in hard tissue regeneration. The specific problem addressed was the need for a biodegradable cement that maintains structural stability while promoting calcification. The motivation stemmed from the limitations of existing cements like brushite, which fail to induce calcification in certain cell types. The researchers sought to determine if CpPC’s polyphosphate structure could influence cellular responses. They focused on dissolution rates and their impact on calcification in MG-63 and ST2 cells. In vivo testing was included to assess tissue integration and bone formation. The study’s design aimed to bridge the gap between material properties and biological outcomes. The goal was to establish CpPC as a viable bone substitute.

The study used calcium polyphosphate cement (CpPC) as the primary material. Basic components were added to control setting time and structural stability. The setting reaction was analyzed for amorphous structure formation and polyphosphate reconstruction. Dissolution rates were compared with brushite cement using standardized methods. Cytotoxicity was assessed in vitro using MG-63 and ST2 cells. Calcification levels were measured through staining and quantification techniques. In vivo experiments involved a rat calvarial defect model. Defect closure and new bone formation were evaluated using histological and radiographic methods. The study combined material characterization with biological and clinical testing to validate CpPC’s potential.

CpPC exhibited a dissolution rate 2.5 times higher than brushite cement. Despite this, no significant cytotoxicity was observed in MG-63 or ST2 cells. Calcification levels increased with higher CpPC dissolution rates in MG-63 cells. Similar calcification was noted in ST2 cells treated with CpPC. In contrast, no calcification was observed in cells treated with brushite cement. In vivo tests showed favorable host responses to CpPC degradation. Defect closure improved significantly in CpPC-treated rats. New bone formation progressed from mid-sites and defect margins. These findings suggest CpPC’s potential as a biodegradable bone substitute. The results support its use in promoting hard tissue regeneration.

The authors concluded that CpPC’s modified polyphosphate structure supports hard tissue regeneration. The material’s high dissolution rate did not lead to cytotoxicity, making it biocompatible. CpPC induced calcification in both MG-63 and ST2 cells, unlike brushite cement. In vivo results confirmed its ability to promote bone formation. The favorable host response and defect closure suggest clinical potential. The study highlights CpPC’s unique properties for bone regeneration. No claims of essentiality or necessity were made beyond the authors’ findings. The conclusions are based on observed calcification and in vivo outcomes.